North America Neurostimulation Devices Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033
The North America neurostimulation devices market size is expected to reach US$ 7.72 billion by 2033 from US$ 3.62 billion in 2025. The market is estimated to register a CAGR of 9.9% from 2026 to 2033.
Report Coverage
- Product Type: Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Transcranial Stimulation Devices, Other Product Types
- Type: Invasive, Non-Invasive
- Application: Pain & Sensory Modulation, Functional Disorders, Cognitive & Behavioral Regulation, Other Applications
- End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
US$ 3.62 Bn
Market size in 2025
US$ 7.72 Bn
Market Size by 2033
9.9%
CAGR, 2026 - 2033
2026-2033
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Neurostimulation Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Neurostimulation Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Neurostimulation Devices Market Regional Analysis
6.2 North America Neurostimulation Devices Market Revenue 2022-2033 (US$ Billion)
6.3 North America Neurostimulation Devices Market Forecast Analysis
7. North America Neurostimulation Devices Market Analysis – by Product Type
7.1 Spinal Cord Stimulation Devices
- 7.1.1 Overview
- 7.1.2 Spinal Cord Stimulation Devices: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.2 Deep Brain Stimulation Devices
- 7.2.1 Overview
- 7.2.2 Deep Brain Stimulation Devices: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.3 Sacral Nerve Stimulation Devices
- 7.3.1 Overview
- 7.3.2 Sacral Nerve Stimulation Devices: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.4 Vagus Nerve Stimulation Devices
- 7.4.1 Overview
- 7.4.2 Vagus Nerve Stimulation Devices: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.5 Transcranial Stimulation Devices
- 7.5.1 Overview
- 7.5.2 Transcranial Stimulation Devices: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.6 Other Product Types
- 7.6.1 Overview
- 7.6.2 Other Product Types: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8. North America Neurostimulation Devices Market Analysis – by Type
8.1 Invasive
- 8.1.1 Overview
- 8.1.2 Invasive: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.2 Non-Invasive
- 8.2.1 Overview
- 8.2.2 Non-Invasive: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9. North America Neurostimulation Devices Market Analysis – by Application
9.1 Pain & Sensory Modulation
- 9.1.1 Overview
- 9.1.2 Pain & Sensory Modulation: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.2 Functional Disorders
- 9.2.1 Overview
- 9.2.2 Functional Disorders: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.3 Cognitive & Behavioral Regulation
- 9.3.1 Overview
- 9.3.2 Cognitive & Behavioral Regulation: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.4 Other Applications
- 9.4.1 Overview
- 9.4.2 Other Applications: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
10. North America Neurostimulation Devices Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
10.2 Specialty Clinics
- 10.2.1 Overview
- 10.2.2 Specialty Clinics: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
10.3 Ambulatory Surgical Centers
- 10.3.1 Overview
- 10.3.2 Ambulatory Surgical Centers: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
10.4 Other End Users
- 10.4.1 Overview
- 10.4.2 Other End Users: North America Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
11. North America Neurostimulation Devices Market – North America Analysis
11.1 Overview
11.2 North America- 11.2.1 North America Neurostimulation Devices Market Breakdown, by Key Country, 2026 and 2033 (%)
- 11.2.1.1 North America Neurostimulation Devices Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 US: North America Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Billion)
- 11.2.1.1.1 US: North America Neurostimulation Devices Market Breakdown, by Product Type
- 11.2.1.1.2 US: North America Neurostimulation Devices Market Breakdown, by Type
- 11.2.1.1.3 US: North America Neurostimulation Devices Market Breakdown, by Application
- 11.2.1.1.4 US: North America Neurostimulation Devices Market Breakdown, by End User
- 11.2.1.2 Canada: North America Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Billion)
- 11.2.1.2.1 Canada: North America Neurostimulation Devices Market Breakdown, by Product Type
- 11.2.1.2.2 Canada: North America Neurostimulation Devices Market Breakdown, by Type
- 11.2.1.2.3 Canada: North America Neurostimulation Devices Market Breakdown, by Application
- 11.2.1.2.4 Canada: North America Neurostimulation Devices Market Breakdown, by End User
- 11.2.1.3 Mexico: North America Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Billion)
- 11.2.1.3.1 Mexico: North America Neurostimulation Devices Market Breakdown, by Product Type
- 11.2.1.3.2 Mexico: North America Neurostimulation Devices Market Breakdown, by Type
- 11.2.1.3.3 Mexico: North America Neurostimulation Devices Market Breakdown, by Application
- 11.2.1.3.4 Mexico: North America Neurostimulation Devices Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Medtronic Plc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Abbott
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Boston Scientific Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 LivaNova Plc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Nevro Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 NeuroPace Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Nexalin Technology
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 ElectroCore Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Biotronik SE & Co KG
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Mainstay Medical
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
